Keyphrases
Hemodynamic Assessment
100%
Nonsustained Ventricular Tachycardia
100%
Procainamide
100%
Left Ventricular Dysfunction
33%
Premature Ventricular Contraction
33%
Ventricular Tachycardia
33%
Transient Left Ventricular Dysfunction
16%
In(III)
16%
Left Ventricular Filling Pressure
16%
Ejection Fraction
16%
Arrhythmia
16%
Oral Administration
16%
Cardiac Volume
16%
Placebo-controlled
16%
Hypotension
16%
Hemodynamic Profile
16%
Cardiac Reserve
16%
Long-term Suppression
16%
Current Population
16%
Fatal Ventricular Arrhythmia
16%
Invasive Hemodynamics
16%
Mildly Symptomatic
16%
Proarrhythmia
16%
Arrhythmic Death
16%
Sustained Ventricular Tachycardia
16%
Poor Risk
16%
Risk-benefit Ratio
16%
Stroke Volume Index
16%
Arrhythmia Suppression
16%
Medicine and Dentistry
Hemodynamic
100%
Nonsustained Ventricular Tachycardia
100%
Antiarrhythmic Drug
100%
Procainamide
100%
Indecainide
100%
Heart Left Ventricle Failure
33%
Premature Ventricular Contraction
22%
Cardiac Dysrhythmia
22%
Ventricular Tachycardia
22%
Placebo
11%
Heart Left Ventricle Filling Pressure
11%
Ejection Fraction
11%
Hypotension
11%
Heart Ventricle Arrhythmia
11%
Oral Drug Administration
11%
Stroke Volume
11%
Risk-Benefit Ratio
11%
Proarrhythmia
11%
Sustained Ventricular Tachycardia
11%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Ventricle Tachycardia
100%
Antiarrhythmic Drug
100%
Indecainide
100%
Procainamide
100%
Heart Left Ventricle Failure
33%
Heart Arrhythmia
22%
Heart Ventricle Extrasystole
22%
Placebo
11%
Heart Ventricle Arrhythmia
11%
Cerebrovascular Accident
11%
Hypotension
11%
Heart Proarrhythmia
11%
Oral Administration
11%